s6y
Company name or ticker
Search
Orexigen Therapeutics, Inc.
3
Lynch Thomas P.: Initial statement of beneficial ownership of securities
Filed
Wednesday, December 2, 2015
Period
Dec 1, 2015
Accession number
0001209191-15-083002
Documents
FORM 3 SUBMISSION
3
POA DOCUMENT
EX-24.3_617516
On sec.gov
Filing index
All files
Complete submission text
SGML header